Key Principle
Scientific progress converts intuitive, expert-dependent medicine into rules-based procedures. Once rules exist, less-trained caregivers -- or patients themselves -- can deliver effective care in simpler, cheaper settings. This is the master mechanism behind health care disruption.
The pattern follows a five-stage sequence: (1) a condition requires expensive experts in centralized facilities; (2) scientific advances convert diagnosis and treatment into rules-based procedures; (3) less-trained caregivers can perform effective care; (4) care moves to more convenient, less expensive venues; (5) more people consume higher-quality care at lower cost.
Why This Matters
Health care contains two independent but reinforcing disruption dimensions:
- Provider-level disruption moves competent care down the skill pyramid (subspecialists > specialists > generalists > nurses > patients). Angioplasty letting cardiologists disrupt cardiac surgeons is the textbook case.
- Point-of-care disruption moves treatment to more convenient settings -- from general hospitals to outpatient facilities to offices to homes. Home pregnancy testing illustrates the full arc.
Both dimensions are driven by the same upstream cause: clearer rules reduce the skill required, enabling simpler procedures by less-trained providers in lower-cost settings.
The dual definition of quality explains why the industry resists reform. In problem-solving mode (upper-left of the disease migration diagram), quality means the most effective care possible. In rules-based mode (lower-right), quality means getting required care as quickly, conveniently, and inexpensively as possible. Conflating the two blocks progress on cost and access.
Good Examples
- Home pregnancy tests: Rabbit test (1930s) to radioimmunoassay (1960s) to enzyme assay to home kits (1970s) to one-step near-perfect accuracy at ~$10 (1990s). Classic disruptive trajectory -- entered low on performance, then rapidly improved. (Ch. 8)
- MinuteClinic: Nurse practitioners in Cub Foods and Target stores in Minnesota. Set menu of disorders, no appointments, most patients in and out within fifteen minutes. The innovation is the business model, not the technology -- low-cost, convenient delivery using the same diagnostic tools. (Ch. 8)
- Home glucose monitors: Patients became so well-informed about managing diabetes they rarely needed endocrinologists -- reducing specialist demand while improving outcomes. (Ch. 8)
- Angioplasty: Initially inferior to CABG (restenosis, limited cases), but simpler, cheaper, less invasive. Grew at ~40% compound rate 1979-1999, exceeded CABG volume in 1997. (Ch. 8)
- Sonosite: Three-pound handheld ultrasound vs. $300,000 stationary machines. Vastly inferior image quality, but enabled ER physicians and nurses to perform tasks previously done by guesswork. Succeeded by avoiding demanding users like cardiologists. (Ch. 8)
Counterpoints
Third-party payment as disruption dampener. "Industries in which consumers do not face a trade-off between performance and cost are undisruptable." (Ch. 8) When insurance flattens copayments, consumers always choose the higher-performing option regardless of true cost. At a flat $5 copay, patients choose the doctor over a nurse practitioner every time -- the mechanism that normally pulls consumers toward disruptors is disabled.
Regulation mismatch. Rules created when conditions were poorly understood remain appropriate for those conditions but become barriers for conditions that have migrated to the rules-based stage. Role limitations prevent nurse practitioners from treating more conditions; approval mechanisms designed for problem-solving-stage diseases are inappropriately applied to rules-based ones.
Path dependency of employer-sponsored insurance. The system arose from 1940s wage freezes -- companies offered health benefits as a workaround, the IRS ruled them nontaxable. This historical accident locks in cost structures and incentive distortions that suppress disruption.
Key Quotes
- "Good, circumstance-based theory is industry-agnostic." (Ch. 8)
- "Industries in which consumers do not face a trade-off between performance and cost are undisruptable." (Ch. 8)
- "The real winner in the future we envision will be consumers, who will increasingly be able to manage their own health in convenient settings at lower costs." (Ch. 8)
- "Procedures that look mundane to highly trained providers often look exciting to less highly trained providers." (Ch. 8)
- "From society's viewpoint, costly and inaccessible health care is not high quality. Any argument based on social good should be for rather than against disruption." (Ch. 8)
- "We predict that removing the third-party payment mechanism will take the cap off the motivation to innovate disruptively." (Ch. 8)
Rules of Thumb
- Target mundane conditions, not the sickest patients. 56 million physician visits in 2000 were for sinus problems, earaches, and sore throats alone -- the largest near-term disruption opportunity. Pursuing the hardest cases produces sustaining innovation, not disruption.
- Sell to nonproviders, not incumbents. A nonprovider's frame of reference is nothing; they adopt eagerly and begin the march upmarket.
- Expose consumers to cost trade-offs. Every policy shift toward consumer cost-bearing (HSAs, high-deductible plans, defined contribution) is simultaneously a disruption-enabling event.
- Invest in simplification, not just frontier science. Augment cutting-edge research with "developing sophisticated technology whose purpose is to simplify delivery and treatment and render them foolproof." (Ch. 8)
- Minimize integration with incumbent value networks. Coupling a new care model to traditional insurance and established providers constrains the freedom to build a genuinely different value proposition.
- Hire for process excellence over medical prestige. "Having experience in an industry that has to get a process right over and over again is even more critical" than high-level medical training for disruptive models. (Ch. 8)
Related References
- Core Framework -- The disruption and new-market theory that health care analysis applies
- Nonmarket Forces -- Motivation-ability framework for regulatory and payment barriers
- Competitive Battles -- Asymmetric motivation between provider tiers
- Strategic Choices -- Target market selection and value network discipline